Application due date: July 13, 2021, by 11:59 PM Eastern Time
The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative research to advance global access to safe and effective biological products that meet international standards.
Topics: Co-Morbidities, COVID-19, Community Engagement, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Wearables, Prevention, PPE, Social Distancing, Research Site, International, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Anti-viral Targets, Immunological Response Targets, Drugs, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy